Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-011412

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 6:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2015M15,000$12.99A57,279IShares held by Bienaime Family Trust
Common StockF2,F1Mar 9, 2015S15,000$112.1206D42,279IShares held by Bienaime Family Trust
Common StockF3,F1Mar 9, 2015S4,000$112.1435D38,279IShares held by Bienaime Family Trust
Common StockF4,F1Mar 10, 2015S2,021$114.894D36,258IShares held by Bienaime Family Trust
Common Stockholding———254,757D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy Common Stock)F1,F5$12.99Mar 9, 2015M15,000DNov 11, 2006May 10, 2016Common Stock15,00046,500I
Stock Option (right to buy Common Stock)F6,F4,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F4,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F4,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F4,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F4,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock20,00020,000I

Explanation of responses